Katakura  Industries  Co.,Ltd. Logo

Katakura Industries Co.,Ltd.

A diversified company in pharmaceuticals, real estate, textiles, and machinery.

3001 | T

Overview

Corporate Details

ISIN(s):
JP3211400001
LEI:
Country:
Japan
Address:
中央区明石町6番4号

Description

Katakura Industries Co., Ltd. is a diversified company with operations organized into several business segments. The primary divisions include pharmaceuticals, real estate, textiles, and machinery. In the pharmaceutical sector, the company manufactures and sells treatments for cardiovascular illnesses, including angina pectoris and cardiac infarction. The real estate division engages in the operation and leasing of properties. The textile segment, which stems from the company's origins in silk manufacturing in 1873, continues to produce and sell various apparel and textile goods. The machinery division complements its industrial activities.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-13 04:45
確認書
Japanese 8.7 KB
2025-08-13 04:43
半期報告書-第117期(2025/01/01-2025/12/31)
Japanese 246.8 KB
2025-06-11 09:00
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.4 KB
2025-04-03 09:00
臨時報告書
Japanese 23.6 KB
2025-03-28 05:22
内部統制報告書-第116期(2024/01/01-2024/12/31)
Japanese 23.3 KB
2025-03-28 05:18
確認書
Japanese 8.7 KB
2025-03-28 05:16
有価証券報告書-第116期(2024/01/01-2024/12/31)
Japanese 1.3 MB
2024-09-11 09:00
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.4 KB
2024-08-09 08:40
確認書
Japanese 8.7 KB
2024-08-09 08:38
半期報告書-第116期(2024/01/01-2024/12/31)
Japanese 254.9 KB
2024-05-14 08:47
確認書
Japanese 8.7 KB
2024-05-14 08:45
四半期報告書-第116期第1四半期(2024/01/01-2024/03/31)
Japanese 192.4 KB
2024-04-03 09:09
臨時報告書
Japanese 30.7 KB
2024-03-28 05:36
内部統制報告書-第115期(2023/01/01-2023/12/31)
Japanese 23.0 KB
2024-03-28 05:33
確認書
Japanese 8.7 KB

Automate Your Workflow. Get a real-time feed of all Katakura Industries Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Katakura Industries Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Katakura Industries Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.